Association of comorbidities with overall survival in myelodysplastic syndrome: Development of a prognostic model

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2240-2246

  Naqvi, Kiran ^a   Garcia Manero, Guillermo ^a   Sardesai, Sagar ^a   Oh, Jeong ^a   Vigil, Carlos E ^a   Pierce, Sherry ^a   Lei, Xiudong ^a   Shan, Jianqin ^a   Kantarjian, Hagop M ^a   Suarez Almazor, Maria E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEOPLASM; NEUROLOGIC DISEASE; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79957943933     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.3353     Document Type: Article

References (28)

1. Tefferi A, Vardiman JW: Myelodysplastic syndromes. N Engl J Med 361:1872-1885, 2009
2. Rollison DE, Howlader N, Smith MT, et al: Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112:45-52, 2008
3. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199, 1982 (Pubitemid 12073508)
4. Vardiman JW, Thiele J, Arber DA, et al: The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 114:937-951, 2009
5. Greenberg P, Cox C, LeBeau MM, et al: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088, 1997 (Pubitemid 27132124)
6. Malcovati L, Germing U, Kuendgen A, et al: Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503-3510, 2007 (Pubitemid 47315575)
7. Kantarjian H, O'Brien S, Ravandi F, et al: Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 113:1351-1361, 2008
8. Garcia-Manero G, Shan J, Faderl S, et al: A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia 22:538-543, 2008 (Pubitemid 351386723)
9. Feinstein AR: The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis 23:455-469, 1970
10. Extermann M: Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 35:181-200, 2000
11. Piccirillo JF: Importance of comorbidity in head and neck cancer. Laryngoscope 110:593-602, 2000
12. Albertsen PC, Fryback DG, Storer BE, et al: The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156:127-132, 1996 (Pubitemid 26185654)
13. Clemens JD, Feinstein AR, Holabird N, et al: A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer. J Chronic Dis 39:913-928, 1986 (Pubitemid 17229989)
14. Yancik R, Wesley MN, Ries LA, et al: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892, 2001 (Pubitemid 32171549)
15. Yancik R, Wesley MN, Ries LA, et al: Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer 82:2123-2134, 1998 (Pubitemid 28240818)
16. DiSilvestro P, Peipert JF, Hogan JW, et al: Prognostic value of clinical variables in ovarian cancer. J Clin Epidemiol 50:501-505, 1997 (Pubitemid 27270199)
17. Wells CK, Stoller JK, Feinstein AR, et al: Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 144:2004-2009, 1984
18. Miller DC, Taub DA, Dunn RL, et al: The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 169:105-109, 2003 (Pubitemid 35461563)
19. Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441-2447, 2004 (Pubitemid 38669187)
20. Sorror ML, Maris MB, Storb R, et al: Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood 106:2912-2919, 2005 (Pubitemid 41510773)
21. Wang R, Gross CP, Halene S, et al: Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes. Leuk Res 33:1594-1598, 2009
22. Piccirillo JF, Costas I, Claybour P, et al: The measurement of comorbidity by cancer registries. J Registry Manag 30:8-14, 2003
23. Malcovati L, Porta MG, Pascutto C, et al: Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making. J Clin Oncol 23:7594-7603, 2005 (Pubitemid 46291823)
24. Della Porta MG, Malcovati L: Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome. Haematologica 94:602-606, 2009
25. Dayyani F, Conley AP, Strom SS, et al: Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer 116:2174-2179, 2010
26. Kaplan MH, Feinstein AR: The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 27:387-404, 1974
27. Stauder R, Nösslinger T, Pfeilstöcker M, et al: Impact of age and comorbidity in myelodysplastic syndromes. J Natl Compr Canc Netw 6:927-934, 2008
28. Pfeilstöcker M, Karlic H, Nösslinger T, et al: Myelodysplastic syndromes, aging, and age: Correlations, common mechanisms, and clinical implications. Leuk Lymphoma 48:1900-1909, 2007